Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR T-Cell Therapy for Leukemia
Recruiting1 awardPhase 1
Seattle, Washington
This trial is testing a new way to treat leukemia by using the patient's own T-cells that have been genetically modified to target a different protein, CD22, that is found on the surface of the leukemia cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service